Literature DB >> 24696483

Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.

Christian Kranjec1, Paola Massimi1, Lawrence Banks2.   

Abstract

UNLABELLED: The cancer-causing high-risk human papillomavirus (HPV) E6 oncoproteins target a number of cellular proteins that contain PDZ domains. However, the role of many of these interactions in either the HPV life cycle or in HPV-induced malignancy remains to be defined. Previous studies had shown that MAGI-1 was one of the most strongly bound PDZ domain-containing substrates of E6, and one consequence of this interaction appeared to facilitate the perturbation of tight junctions (TJs) by E6. In this study, we describe the generation of a mutation, K499E, within the MAGI-1 PDZ1 domain, which is resistant to E6 targeting. This mutant allows restoration of MAGI-1 expression in HPV-positive cells and defines additional activities of MAGI-1 that are overcome as a consequence of the association with E6. The reexpression of MAGI-1 in HPV-positive cells results in an increased recruitment of ZO-1 and PAR3 to sites of cell-cell contact, repression of cell proliferation, and induction of apoptosis. While the K499E mutation does not significantly affect these intrinsic activities of MAGI-1 in HPV-negative cells, its resistance to E6 targeting in an HPV-positive setting results in more cells expressing the mutant MAGI-1 than the wild-type MAGI-1, with a corresponding increase in TJ assembly, induction of apoptosis, and reduction in cell proliferation. These studies provide compelling evidence of a direct role for the perturbation of MAGI-1 function by E6 in the HPV life cycle and in HPV-induced malignancy. IMPORTANCE: It is clear that the targeting of PDZ-containing substrates by E6 is important for the normal viral life cycle and for the progression to malignancy. Nevertheless, which of these PDZ domain-containing proteins is relevant for HPV pathology is still elusive. In a previous study, we provided evidence that MAGI-1 is a sensitive proteolytic substrate for both the HPV-16 and HPV-18 E6 oncoproteins; however, the biological consequences associated with loss of MAGI-1 expression in HPV-positive cervical cancer cells are still poorly understood. Using a mutant MAGI-1, resistant to E6-mediated degradation, we show that its expression in cervical cancer cells promotes membrane recruitment of the tight junction-associated proteins ZO-1 and PAR3, represses cell proliferation, and promotes apoptosis. These findings suggest that E6-mediated inhibition of MAGI-1 function contributes to HPV pathology by perturbing tight junction assembly with concomitant stimulation of proliferation and inhibition of apoptosis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696483      PMCID: PMC4054424          DOI: 10.1128/JVI.03247-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  MAGI-1 interacts with beta-catenin and is associated with cell-cell adhesion structures.

Authors:  I Y Dobrosotskaya; G L James
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

2.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

Authors:  B A Glaunsinger; S S Lee; M Thomas; L Banks; R Javier
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

3.  Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1.

Authors:  I Y Dobrosotskaya
Journal:  Biochem Biophys Res Commun       Date:  2001-05-18       Impact factor: 3.575

Review 4.  Transmembrane proteins of tight junctions.

Authors:  M S Balda; K Matter
Journal:  Semin Cell Dev Biol       Date:  2000-08       Impact factor: 7.727

5.  Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.

Authors:  S Nakagawa; J M Huibregtse
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Complex phenotype of mice lacking occludin, a component of tight junction strands.

Authors:  M Saitou; M Furuse; H Sasaki; J D Schulzke; M Fromm; H Takano; T Noda; S Tsukita
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

7.  HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.

Authors:  M Thomas; B Glaunsinger; D Pim; R Javier; L Banks
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

8.  Membrane-associated guanylate kinase with inverted orientation (MAGI)-1/brain angiogenesis inhibitor 1-associated protein (BAP1) as a scaffolding molecule for Rap small G protein GDP/GTP exchange protein at tight junctions.

Authors:  A Mino; T Ohtsuka; E Inoue; Y Takai
Journal:  Genes Cells       Date:  2000-12       Impact factor: 1.891

9.  Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin.

Authors:  D Li; R J Mrsny
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

10.  The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.

Authors:  Craig P Delury; Elizabeth K Marsh; Claire D James; Siaw Shi Boon; Lawrence Banks; Gillian L Knight; Sally Roberts
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

View more
  21 in total

1.  The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).

Authors:  Ran Yan; Priyanka Sharma; Abimbola O Kolawole; Sterling C T Martin; James M Readler; Poornima L N Kotha; Heather A Hostetler; Katherine J D A Excoffon
Journal:  Int J Biochem Cell Biol       Date:  2015-01-23       Impact factor: 5.085

2.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

3.  MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer.

Authors:  Shuqin Jia; Jiajia Lu; Tingting Qu; Yi Feng; Xiaohong Wang; Caixia Liu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

4.  PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.

Authors:  Nathaniel Edward Bennett Saidu; Vedrana Filić; Miranda Thomas; Vanessa Sarabia-Vega; Anamaria Đukić; Frane Miljković; Lawrence Banks; Vjekoslav Tomaić
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

5.  Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.

Authors:  Linda D Mellby; Andreas P Nyberg; Julia S Johansen; Christer Wingren; Børge G Nordestgaard; Stig E Bojesen; Breeana L Mitchell; Brett C Sheppard; Rosalie C Sears; Carl A K Borrebaeck
Journal:  J Clin Oncol       Date:  2018-08-14       Impact factor: 44.544

6.  MAGI-1 PDZ2 Domain Blockade Averts Adenovirus Infection via Enhanced Proteolysis of the Apical Coxsackievirus and Adenovirus Receptor.

Authors:  Mahmoud S Alghamri; Priyanka Sharma; Timothy L Williamson; James M Readler; Ran Yan; S Dean Rider; Heather A Hostetler; David R Cool; Abimbola O Kolawole; Katherine J D A Excoffon
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

Review 7.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

8.  Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.

Authors:  Juan Ramirez; Juline Poirson; Clémence Foltz; Yassmine Chebaro; Maxime Schrapp; Amandine Meyer; Anaëlle Bonetta; Anne Forster; Yves Jacob; Murielle Masson; François Deryckère; Gilles Travé
Journal:  Angew Chem Int Ed Engl       Date:  2015-05-27       Impact factor: 15.336

Review 9.  The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.

Authors:  Ketaki Ganti; Justyna Broniarczyk; Wiem Manoubi; Paola Massimi; Suruchi Mittal; David Pim; Anita Szalmas; Jayashree Thatte; Miranda Thomas; Vjekoslav Tomaić; Lawrence Banks
Journal:  Viruses       Date:  2015-07-02       Impact factor: 5.048

Review 10.  PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.

Authors:  Lennox Chitsike; Penelope J Duerksen-Hughes
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.